(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

THERABIOPHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

THERABIOPHARMA

ST13

US500000079272345

Class

5, 30, 32

Filing

79272345

Registration

6599486

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

44

Latest update

10/05/2022

Trademark type

Combined

Nice classes

5, 30, 32

Filing date

09/05/2019

Registration date

12/28/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/28/2021

Last transaction

01/27/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

03

Owner location

JP

Examiner

PODESTA, GIDETTE

Law office

N70

Current location

TMO LAW OFFICE 125

Holders and representatives

Holders

Therabiopharma Inc.

Representatives

KAREN LIM FROSS ZELNICK LEHRMAN & ZISSU, P.C.

Technical classification

Nice Classes

Class 5Class 30Class 32

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationsanticancer medicineanti-inflammatory medicineanti-allergic medicinecardiovascular disease medicine including heart disease medicinemetabolic syndrome medicineneurodegenerative disease medicineautoimmune disease medicine and infectious disease medicine in each case derived from natural and/or synthesised curcumin including derivatives and analogues of curcumin as well as mixtures of curcumin and derivatives and analogues of curcumin with other chemical compounds; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes

Class 30

Tea; coffee; cocoa; non-medicated confectionerychocolatescandiesgummy candies and fruit jelly candies; bread; spices; roasted coffee beans; cereal preparationscereal-based snack foodscereal barsprocessed cereal-based food to be used as a breakfast foodsnack food or ingredient for making other foods; chocolate-based spreads

Class 32

Beer; soft drinks; fruit juices; beveragesvegetable juices; extracts of hops for making beer; whey beverages

Publications

History of USPTO decisions and trademark events.

44 publications found

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

10/05/2022

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

09/26/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/05/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/09/2022

FIMP

FINAL DISPOSITION PROCESSED

06/08/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/28/2022

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

01/26/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

12/28/2021

TMBN

TTAB RELEASE CASE TO TRADEMARKS

11/18/2021

OP.T

OPPOSITION TERMINATED NO. 999999

11/18/2021

OP.D

OPPOSITION DISMISSED NO. 999999

11/18/2021

LIME

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

08/03/2021

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

06/19/2021

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

05/10/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/21/2021

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

04/21/2021

RFNP

REFUSAL PROCESSED BY IB

03/21/2021

OP.I

OPPOSITION INSTITUTED NO. 999999

02/26/2021

OPNS

OPPOSITION NOTICE (IB REFUSAL) SENT TO IB

02/23/2021

OPNC

OPPOSITION NOTICE (IB REFUSAL) CREATED

02/23/2021

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

09/16/2020

NREP

NEW REPRESENTATIVE AT IB RECEIVED

09/11/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/25/2020

PUBO

PUBLISHED FOR OPPOSITION

08/25/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/05/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/23/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/22/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/21/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/21/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/18/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/18/2020

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

06/18/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/18/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/18/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/18/2020

RFNT

REFUSAL PROCESSED BY IB

02/08/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/21/2020

RFRR

REFUSAL PROCESSED BY MPU

01/21/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/13/2019

CNRT

NON-FINAL ACTION WRITTEN

12/12/2019

DOCK

ASSIGNED TO EXAMINER

12/06/2019

MAFR

APPLICATION FILING RECEIPT MAILED

11/30/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/26/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/21/2019

Continuous trademark protection

Get notified about every new filing that threatens THERABIOPHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.